Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
217 | 3904 | 43.2 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
364 | 3 | TELOMERASE//TELOMERE//C ELEGANS | 34320 |
700 | 2 | TELOMERASE//TELOMERE//TELOMERE LENGTH | 12973 |
217 | 1 | TELOMERASE//HTERT//TELOMERASE ACTIVITY | 3904 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TELOMERASE | authKW | 5329826 | 40% | 44% | 1545 |
2 | HTERT | authKW | 1648578 | 10% | 54% | 391 |
3 | TELOMERASE ACTIVITY | authKW | 1252499 | 7% | 60% | 267 |
4 | TELOMERE | authKW | 729485 | 15% | 16% | 591 |
5 | HUMAN TELOMERASE REVERSE TRANSCRIPTASE | authKW | 477420 | 3% | 58% | 106 |
6 | TRAP ASSAY | authKW | 337207 | 2% | 65% | 66 |
7 | HTR | authKW | 214047 | 1% | 54% | 51 |
8 | TELOMERASE REVERSE TRANSCRIPTASE | authKW | 191505 | 2% | 39% | 63 |
9 | TELOMERIC REPEAT AMPLIFICATION PROTOCOL | authKW | 172357 | 1% | 96% | 23 |
10 | TERT | authKW | 141689 | 2% | 26% | 71 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 20292 | 38% | 0% | 1478 |
2 | Cell Biology | 3894 | 18% | 0% | 689 |
3 | Biochemistry & Molecular Biology | 1813 | 22% | 0% | 840 |
4 | Pathology | 1189 | 6% | 0% | 218 |
5 | Genetics & Heredity | 1052 | 8% | 0% | 319 |
6 | Hematology | 896 | 5% | 0% | 211 |
7 | Medicine, Research & Experimental | 710 | 6% | 0% | 241 |
8 | Geriatrics & Gerontology | 367 | 2% | 0% | 75 |
9 | Biophysics | 342 | 5% | 0% | 176 |
10 | Gastroenterology & Hepatology | 341 | 4% | 0% | 142 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMREPMOL SIGNALLING | 23459 | 0% | 100% | 3 |
2 | HIV AIDS MALIGNANCIES BRANCH | 23459 | 0% | 100% | 3 |
3 | PATHOL PL CANC | 17870 | 0% | 57% | 4 |
4 | NFKB SIGNALING | 17593 | 0% | 75% | 3 |
5 | MOL BIOL CYTOGENET | 17380 | 0% | 14% | 16 |
6 | ONCOL PL PHARMACOL | 16293 | 0% | 16% | 13 |
7 | ABT MOL BIOANALYT BIOELEKT | 15639 | 0% | 100% | 2 |
8 | CANC BIOIMMUNOTHER Y UNIT MED ONCOL | 15639 | 0% | 100% | 2 |
9 | CHARLIE CONACHER CANC | 15639 | 0% | 100% | 2 |
10 | CYTOGENET PREVENT ONCOL | 15639 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF ONCOLOGY | 8066 | 3% | 1% | 100 |
2 | JOURNAL OF ANTI-AGING MEDICINE | 6402 | 0% | 10% | 8 |
3 | ONCOGENE | 5459 | 3% | 1% | 114 |
4 | ONCOLOGY REPORTS | 2293 | 1% | 1% | 55 |
5 | NEOPLASIA | 2009 | 1% | 1% | 21 |
6 | CANCER RESEARCH | 2002 | 3% | 0% | 104 |
7 | CLINICAL CANCER RESEARCH | 1986 | 2% | 0% | 63 |
8 | UROLOGIC ONCOLOGY | 1768 | 0% | 5% | 5 |
9 | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 1319 | 1% | 1% | 31 |
10 | CURRENT MOLECULAR MEDICINE | 1126 | 0% | 1% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TELOMERASE | 5329826 | 40% | 44% | 1545 | Search TELOMERASE | Search TELOMERASE |
2 | HTERT | 1648578 | 10% | 54% | 391 | Search HTERT | Search HTERT |
3 | TELOMERASE ACTIVITY | 1252499 | 7% | 60% | 267 | Search TELOMERASE+ACTIVITY | Search TELOMERASE+ACTIVITY |
4 | TELOMERE | 729485 | 15% | 16% | 591 | Search TELOMERE | Search TELOMERE |
5 | HUMAN TELOMERASE REVERSE TRANSCRIPTASE | 477420 | 3% | 58% | 106 | Search HUMAN+TELOMERASE+REVERSE+TRANSCRIPTASE | Search HUMAN+TELOMERASE+REVERSE+TRANSCRIPTASE |
6 | TRAP ASSAY | 337207 | 2% | 65% | 66 | Search TRAP+ASSAY | Search TRAP+ASSAY |
7 | HTR | 214047 | 1% | 54% | 51 | Search HTR | Search HTR |
8 | TELOMERASE REVERSE TRANSCRIPTASE | 191505 | 2% | 39% | 63 | Search TELOMERASE+REVERSE+TRANSCRIPTASE | Search TELOMERASE+REVERSE+TRANSCRIPTASE |
9 | TELOMERIC REPEAT AMPLIFICATION PROTOCOL | 172357 | 1% | 96% | 23 | Search TELOMERIC+REPEAT+AMPLIFICATION+PROTOCOL | Search TELOMERIC+REPEAT+AMPLIFICATION+PROTOCOL |
10 | TERT | 141689 | 2% | 26% | 71 | Search TERT | Search TERT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHEN, CH , CHEN, RJ , (2011) PREVALENCE OF TELOMERASE ACTIVITY IN HUMAN CANCER.JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION. VOL. 110. ISSUE 5. P. 275-289 | 122 | 92% | 27 |
2 | HIYAMA, E , HIYAMA, K , (2004) TELOMERASE DETECTION IN THE DIAGNOSIS AND PROGNOSIS OF CANCER.CYTOTECHNOLOGY. VOL. 45. ISSUE 1-2. P. 61-74 | 123 | 94% | 9 |
3 | LAMY, E , GOETZ, V , ERLACHER, M , HERZ, C , MERSCH-SUNDERMANN, V , (2013) HTERT: ANOTHER BRICK IN THE WALL OF CANCER CELLS.MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH. VOL. 752. ISSUE 2. P. 119-128 | 121 | 70% | 7 |
4 | PENDINO, F , TARKANYI, I , DUDOGNON, C , HILLION, J , LANOTTE, M , ARADI, J , SEGAL-BENDIRDJIAN, E , (2006) TELOMERES AND TELOMERASE: PHARMACOLOGICAL TARGETS FOR NEW ANTICANCER STRATEGIES?.CURRENT CANCER DRUG TARGETS. VOL. 6. ISSUE 2. P. 147 -180 | 183 | 52% | 48 |
5 | SEKARAN, V , SOARES, J , JARSTFER, MB , (2014) TELOMERE MAINTENANCE AS A TARGET FOR DRUG DISCOVERY.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 57. ISSUE 3. P. 521 -538 | 121 | 56% | 28 |
6 | DEVILLE, L , HILLION, J , SEGAL-BENDIRDJIAN, E , (2009) TELOMERASE REGULATION IN HEMATOLOGICAL CANCERS: A MATTER OF STEMNESS?.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. VOL. 1792. ISSUE 4. P. 229 -239 | 129 | 68% | 16 |
7 | SKVORTZOV, DA , RUBZOVA, MP , ZVEREVA, ME , KISELEV, FL , DONZOVA, OA , (2009) THE REGULATION OF TELOMERASE IN ONCOGENESIS.ACTA NATURAE. VOL. 1. ISSUE 1. P. 51 -67 | 128 | 70% | 3 |
8 | COLANGELO, D , OSELLA, D , (2005) TELOMERASE INHIBITION AND CANCER: MIGHT PLATINUM BASED DRUGS HAVE A FUTURE AS ANTI-TELOMERASE PHARMACOLOGICAL APPROACH?.CURRENT MEDICINAL CHEMISTRY. VOL. 12. ISSUE 26. P. 3091-3102 | 169 | 56% | 14 |
9 | CONG, YS , WRIGHT, WE , SHAY, JW , (2002) HUMAN TELOMERASE AND ITS REGULATION.MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS. VOL. 66. ISSUE 3. P. 407-+ | 133 | 52% | 402 |
10 | HIYAMA, E , HIYAMA, K , (2003) TELOMERASE AS TUMOR MARKER.CANCER LETTERS. VOL. 194. ISSUE 2. P. 221-233 | 94 | 92% | 108 |
Classes with closest relation at Level 1 |